AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2010

Jun 12, 2010

35599_dirs_2010-06-11_2e5f2e96-0144-4682-b062-ee4802d6eb18.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2010-06-08

Reporting Person: Butts Robert W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-06-08	Common Shares	P	0	—	Acquired	41504000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-08	Common Stock Warrants (right to buy)	$0.08	P	0	Disposed	2015-04-30	Common Stock (41504000)	Direct

Footnotes

F1: The reported securities are included within 41,504,000 units purchased by reporting person for CDN$0.03 per unit. Each unit
consists of one share of common stock of Adherex Technologies Inc. and one warrant to purchase one share of common stock of
Adherex Technologies Inc.